Literature DB >> 24350766

Respiratory syncytial virus in critically ill adult patients with community-acquired respiratory failure: a prospective observational study.

D S Y Ong1, T E Faber, P M C Klein Klouwenberg, O L Cremer, E Christiaan Boerma, M Sietses, A M van Loon, M J M Bonten, L J Bont.   

Abstract

The incidence of respiratory syncytial virus (RSV) and influenza virus infection was determined during three RSV seasons in 158 adult patients consecutively admitted to the intensive care unit with community-acquired respiratory failure. Nasopharyngeal swabs were tested for the presence of RSV and influenza virus by real-time polymerase chain reaction. Six patients (4%) were positive for RSV and all recovered. This finding was in sharp contrast to influenza (23 (15%) patients, 4 (17%) deaths). In conclusion, even in the midst of the RSV season, RSV is an infrequent cause of respiratory failure in adults admitted to the intensive care unit.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Adult; influenza; intensive care unit; respiratory failure; respiratory syncytial virus

Mesh:

Year:  2014        PMID: 24350766     DOI: 10.1111/1469-0691.12503

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Risk of mortality associated with respiratory syncytial virus and influenza infection in adults.

Authors:  Yong Shik Kwon; Sun Hyo Park; Mi-Ae Kim; Hyun Jung Kim; Jae Seok Park; Mi Young Lee; Choong Won Lee; Sonila Dauti; Won-Il Choi
Journal:  BMC Infect Dis       Date:  2017-12-20       Impact factor: 3.090

2.  Clinical practice of respiratory virus diagnostics in critically ill patients with a suspected pneumonia: A prospective observational study.

Authors:  Frank van Someren Gréve; David S Y Ong; Olaf L Cremer; Marc J M Bonten; Lieuwe D J Bos; Menno D de Jong; Marcus J Schultz; Nicole P Juffermans
Journal:  J Clin Virol       Date:  2016-08-16       Impact factor: 3.168

3.  The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.

Authors:  S M Huijts; F E J Coenjaerts; M Bolkenbaas; C H van Werkhoven; D E Grobbee; M J M Bonten
Journal:  Clin Microbiol Infect       Date:  2017-10-16       Impact factor: 8.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.